Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Julia Xiong"'
Autor:
Reilly D. Hobbs, Megan L. Schultz, Megan L. Loney, Sonaal Verma, Julia Xiong, Richard G. Ohye, Edward Bove, Ming-Sing Si
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 165:251-259
The Ross procedure is a preferred treatment for infants and children with aortic valve disease. Progressive neoaortic root dilation and neoaortic insufficiency can occur after the Ross procedure, and because of the young age of these patients, valve-
Autor:
Reilly D. Hobbs, Megan Schultz, Megan Loney, Sonaal Verma, Julia Xiong, Eric Smith, Richard G. Ohye, Edward Bove, Ming-Sing
Background Aortic root dilatation and aortic insufficiency can occur in patients with prior conotruncal defect surgery, the Ross procedure, and connective tissue disease (CTD). Valve-sparing aortic root replacement (VSRR) is an excellent choice for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6b1a162f6232ed81203a04440704840
https://doi.org/10.22541/au.164442629.99323326/v1
https://doi.org/10.22541/au.164442629.99323326/v1
Autor:
David M. Loeb, Ji Won Lee, Daniel A. Morgenstern, Yvan Samson, Anne Uyttebroeck, Chuhl Joo Lyu, An Van Damme, Karsten Nysom, Margaret E. Macy, Alexandra P. Zorzi, Julia Xiong, Petra Pollert, Ingrid Joerg, Yulia Vugmeyster, Mary Ruisi, Hyoung Jin Kang
Publikováno v:
Paediatrics Publications
Background We report dose-escalation results from an open-label, phase 1/2 trial evaluating avelumab (anti-PD-L1) in paediatric patients with refractory/relapsed solid tumours. Methods In phase 1, patients aged Results At data cut-off (27 July 2021),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fc75339daa271ba07e50e0a785c48fa
https://ir.lib.uwo.ca/paedpub/1593
https://ir.lib.uwo.ca/paedpub/1593
Autor:
Kiran Ganga, Jessica Grieger, Marla Lujan, Julia Michalak, Lisa Moran, Stephen Parry, Chau Thien Tay, Cynthia Wan, Isabella Xavier, Julia Xiong, Maryam Kazemi, Joy Kim
Publikováno v:
Journal of the Endocrine Society. 6:A690-A690
Women with polycystic ovary syndrome (PCOS) exhibit a propensity for obesity and weight gain during their reproductive years. Accordingly, lifestyle (dietary and/or physical activity [PA]) modification is recommended as first-line therapy to manage P
Autor:
Jérôme Fayette, Tanguy Seiwert, Robert L. Ferris, Kevin Harrington, Robert Haddad, Makoto Tahara, Lisa Licitra, Lillian L. Siu, Jean-Pascal Machiels, Malgorzata Dominiewska, Julia Xiong, Paramjit Kaur, Dario Ruscica, Roger B. Cohen
Publikováno v:
Cancer Research. 82:CT236-CT236
Background: Head and neck (HN) cancer is the 7th most common cancer and 7th leading cause of cancer death worldwide with approximately 930,000 new cases and 470,000 deaths in 2020.1 HN squamous cell carcinoma (HNSCC) accounts for around 90% of HN can
Autor:
Junyuan Julia Xiong
Cancer has a big impact on public health. The years of life and productivity lost to diseases and death, and the economic burden to the community make cancer a focus of public health. Efficiency in drug development in oncology area is critical as it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69a34702846d425b5f0bba5af43cd414
Autor:
Do-Youn Oh, Aiwu Ruth He, Shukui Qin, Li-Tzong Chen, Takuji Okusaka, Arndt Vogel, Jin Won Kim, Thatthan Suksombooncharoen, Myung Ah Lee, Masayuki Kitano, Howard A. Burris III, Mohamed Bouattour, Suebpong Tanasanvimon, Renata Zaucha, Antonio Avallone, Juan Cundom, Nana Rokutanda, Julia Xiong, Gordon Cohen, Juan W. Valle
Publikováno v:
Journal of Clinical Oncology. 40:378-378
378 Background: BTC is a rare, heterogenous cancer with poor prognosis. Reports on immunogenic features of BTC suggest checkpoint inhibition may result in antitumor immune responses, and limited clinical activity has been seen with single agents in a
Autor:
Arndt Vogel, Li-Tzong Chen, Aiwu Ruth He, Jin Won Kim, Ming-Huang Chen, Mairéad Mcnamara, Satoshi Shimizu, Roopinder Gillmore, Felipe Ray, Hyosung Kim, Julia Xiong, Mallory Makowsky, Nana Rokutanda, Gordon Cohen, Do-Youn Oh
Publikováno v:
University of Manchester-PURE
4075 Background: TOPAZ-1 (NCT03875235) is a randomized, double-blind, global, Phase 3 study evaluating the efficacy and safety of D + GC as first-line treatment for patients (pts) with advanced BTC. D + GC significantly improved overall survival (OS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e2ed1e3dfcc2a80593777f64027feaa
https://research.manchester.ac.uk/en/publications/5b53ebc5-ef82-4299-9799-e66ba1b0543c
https://research.manchester.ac.uk/en/publications/5b53ebc5-ef82-4299-9799-e66ba1b0543c